Skip to main content
Top
Literature
1.
go back to reference Nadarajah VD, van Putten M, Chaouch A, Garrood P, Straub V, Lochmuller H, Ginjaar HB, Aartsma-Rus AM, van Ommen GJ, den Dunnen JT, t Hoen PA (2011) Serum matrix metalloproteinase-9 (MMP-9) as a biomarker for monitoring disease progression in Duchenne muscular dystrophy (DMD). Neuromuscul Disord 21:569–578CrossRefPubMed Nadarajah VD, van Putten M, Chaouch A, Garrood P, Straub V, Lochmuller H, Ginjaar HB, Aartsma-Rus AM, van Ommen GJ, den Dunnen JT, t Hoen PA (2011) Serum matrix metalloproteinase-9 (MMP-9) as a biomarker for monitoring disease progression in Duchenne muscular dystrophy (DMD). Neuromuscul Disord 21:569–578CrossRefPubMed
2.
go back to reference Schade van Westrum S, Dekker L, de Haan R, Endert E, Ginjaar I, de Visser M, van der Kooi A (2013) Brain natriuretic peptide is not predictive of dilated cardiomyopathy in Becker and Duchenne muscular dystrophy patients and carriers. BMC Neurol 13:88CrossRef Schade van Westrum S, Dekker L, de Haan R, Endert E, Ginjaar I, de Visser M, van der Kooi A (2013) Brain natriuretic peptide is not predictive of dilated cardiomyopathy in Becker and Duchenne muscular dystrophy patients and carriers. BMC Neurol 13:88CrossRef
Metadata
Title
Response to Letter to the Editor
Author
Christopher F. Spurney
Publication date
01-01-2018
Publisher
Springer US
Published in
Pediatric Cardiology / Issue 1/2018
Print ISSN: 0172-0643
Electronic ISSN: 1432-1971
DOI
https://doi.org/10.1007/s00246-017-1792-5

Other articles of this Issue 1/2018

Pediatric Cardiology 1/2018 Go to the issue